Arkolith/Insider Trading/CBIO/Form 4

Pinkas Jan

Chief Scientific OfficerCRESCENT BIOPHARMA, INC. (CBIO) · full profile →Form 4 · filed Jun 23, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$23K
Net Open-Market Flow
-$23K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 22, 2026Sell(S)1K$17.99$23K22K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-044892) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML